MGNX
Price
$1.31
Change
-$0.05 (-3.65%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
82.96M
52 days until earnings call
PTCT
Price
$50.20
Change
-$0.23 (-0.46%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
3.98B
40 days until earnings call
Interact to see
Advertisement

MGNX vs PTCT

Header iconMGNX vs PTCT Comparison
Open Charts MGNX vs PTCTBanner chart's image
MacroGenics
Price$1.31
Change-$0.05 (-3.65%)
Volume$4.4K
Capitalization82.96M
PTC Therapeutics
Price$50.20
Change-$0.23 (-0.46%)
Volume$28.77K
Capitalization3.98B
MGNX vs PTCT Comparison Chart in %
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. PTCT commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and PTCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (MGNX: $1.32 vs. PTCT: $50.20)
Brand notoriety: MGNX and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 61% vs. PTCT: 268%
Market capitalization -- MGNX: $82.96M vs. PTCT: $3.98B
MGNX [@Biotechnology] is valued at $82.96M. PTCT’s [@Biotechnology] market capitalization is $3.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCT’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • PTCT’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, PTCT is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 3 TA indicator(s) are bullish while PTCT’s TA Score has 5 bullish TA indicator(s).

  • MGNX’s TA Score: 3 bullish, 6 bearish.
  • PTCT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PTCT is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а -13.49% price change this week, while PTCT (@Biotechnology) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

MGNX is expected to report earnings on Aug 12, 2025.

PTCT is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($3.98B) has a higher market cap than MGNX($83M). PTCT YTD gains are higher at: 11.210 vs. MGNX (-59.538). PTCT has higher annual earnings (EBITDA): 839M vs. MGNX (-47.33M). PTCT has more cash in the bank: 2.03B vs. MGNX (154M). MGNX has less debt than PTCT: MGNX (37.5M) vs PTCT (390M). PTCT has higher revenues than MGNX: PTCT (1.77B) vs MGNX (152M).
MGNXPTCTMGNX / PTCT
Capitalization83M3.98B2%
EBITDA-47.33M839M-6%
Gain YTD-59.53811.210-531%
P/E RatioN/A7.71-
Revenue152M1.77B9%
Total Cash154M2.03B8%
Total Debt37.5M390M10%
FUNDAMENTALS RATINGS
PTCT vs MGNX: Fundamental Ratings
PTCT
MGNX
OUTLOOK RATING
1..100
1385
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4893
P/E GROWTH RATING
1..100
1794
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGNX's Valuation (81) in the Biotechnology industry is in the same range as PTCT (99). This means that MGNX’s stock grew similarly to PTCT’s over the last 12 months.

MGNX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTCT (100). This means that MGNX’s stock grew similarly to PTCT’s over the last 12 months.

MGNX's SMR Rating (97) in the Biotechnology industry is in the same range as PTCT (100). This means that MGNX’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for MGNX (93). This means that PTCT’s stock grew somewhat faster than MGNX’s over the last 12 months.

PTCT's P/E Growth Rating (17) in the Biotechnology industry is significantly better than the same rating for MGNX (94). This means that PTCT’s stock grew significantly faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXPTCT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BUDZ0.03N/A
+5.85%
WEED, Inc.
STRNY36.39-0.28
-0.76%
Severn Trent PLC
FRMO8.39-0.12
-1.41%
FRMO Corp.
DKILY10.93-0.16
-1.44%
Daikin Industries Ltd.
DSCSY24.53-0.62
-2.46%
Disco Corp.

MGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-4.01%
CRBU - MGNX
52%
Loosely correlated
+4.69%
XNCR - MGNX
50%
Loosely correlated
+2.03%
BEAM - MGNX
46%
Loosely correlated
-1.29%
RGNX - MGNX
46%
Loosely correlated
-1.52%
FATE - MGNX
46%
Loosely correlated
-2.89%
More

PTCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with ACLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-0.46%
ACLX - PTCT
45%
Loosely correlated
-1.28%
RXRX - PTCT
43%
Loosely correlated
-1.76%
XNCR - PTCT
43%
Loosely correlated
+2.03%
BEAM - PTCT
42%
Loosely correlated
-1.29%
IDYA - PTCT
42%
Loosely correlated
-0.87%
More